HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Hebert Selected Research

MZ 5-156

7/2000Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways.
1/2000Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Hebert Research Topics

Disease

7Neoplasms (Cancer)
10/2001 - 01/2000
2Carcinoma (Carcinomatosis)
10/2001 - 09/2001
2Ovarian Neoplasms (Ovarian Cancer)
09/2001 - 10/2000
2Pancreatic Neoplasms (Pancreatic Cancer)
09/2001 - 01/2000
1Breast Neoplasms (Breast Cancer)
10/2001
1Carcinogenesis
10/2001
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2001
1Necrosis
03/2001
1Ovarian Epithelial Carcinoma
10/2000
1Prostatic Neoplasms (Prostate Cancer)
07/2000
1Neoplasm Metastasis (Metastasis)
06/2000
1Renal Cell Carcinoma (Grawitz Tumor)
06/2000

Drug/Important Bio-Agent (IBA)

6Messenger RNA (mRNA)IBA
10/2001 - 01/2000
4Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
09/2001 - 06/2000
3Insulin-Like Growth Factor I (IGF-1)IBA
10/2001 - 01/2000
3AN 238IBA
09/2001 - 06/2000
3Somatostatin Receptors (Somatostatin Receptor)IBA
09/2001 - 06/2000
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2001 - 07/2000
2JV 1-38IBA
10/2001 - 07/2000
2Gastrin-Releasing PeptideIBA
09/2001 - 07/2000
2BombesinIBA
09/2001 - 07/2000
2Epidermal Growth Factor (EGF)IBA
09/2001 - 07/2000
2AN 204 (AN 201)IBA
09/2001 - 06/2000
2Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
07/2000 - 01/2000
2MZ 5-156IBA
07/2000 - 01/2000
2Insulin-Like Growth Factor II (Somatomedin A)IBA
07/2000 - 01/2000
1JV 1-36IBA
10/2001
1Estrogens (Estrogen)FDA Link
10/2001
1neuromedin BIBA
09/2001
1Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)- bombesin (6-14)IBA
09/2001
1cetrorelix (Cetrotide)FDA Link
09/2001
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
09/2001
1RC 121IBA
09/2001
1Radioisotopes (Radionuclides)IBA
10/2000
1vapreotideIBA
10/2000
1LigandsIBA
10/2000
1ErbB Receptors (EGF Receptor)IBA
07/2000
1NeuropeptidesIBA
07/2000
1AndrogensIBA
07/2000
1Hca(6)-Leu(13)-psi(CH2N)-Tac(14)- bombesin(6-14)IBA
07/2000
1Capsules (Microcapsules)IBA
06/2000
1nucleolar organizer region associated proteinsIBA
01/2000
1MZ 4-71IBA
01/2000
1Insulin-Like PeptidesIBA
01/2000

Therapy/Procedure

4Therapeutics
10/2001 - 01/2000
2Injections
03/2001 - 06/2000
1Drug Therapy (Chemotherapy)
06/2000